Oct 13, 2026· Comment from American Pharmacists Association· FDA-2026-N-7542-0444
Dear Deputy Commissioner Graham, The American Pharmacists Association (APhA) appreciates the opportunity to provide FDA comments on the "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments." APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.